Refractory sle patients respond to the proteasome inhibitor bortezomib

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2012
This article has no abstract
Epistemonikos ID: 20190f55389b2452f7fd241b56d14b1ec5123945
First added on: Feb 05, 2025